GI Partners Acquires CDMO and Cell Solutions Businesses from Charles River Laboratories to Form Rose BioSolutions
GI Partners has completed the acquisition of Charles River Laboratories' CDMO and Cell Solutions businesses, forming Rose BioSolutions, a standalone company focused on advanced therapy manufacturing. The new entity aims to leverage GI Partners' resources to drive innovation and expand capabilities in cell and gene therapy. The transaction is expected to enhance operational efficiency and client service in the biopharma sector.
Tickers: $CRL
Topics: Biotech CDMO Cell and Gene Therapy M&A Private Equity